SugarMD Alpha Lipoic Acid 600 MG – 60 Capsules

Elevate your wellness with SugarMD Alpha Lipoic Acid, a potent 600 mg antioxidant formula designed to support multiple aspects of your metabolic and cellular health.

• Potent 600 mg Per Capsule: Each serving delivers 600 mg of premium Alpha Lipoic Acid (ALA)², a powerful, versatile antioxidant for comprehensive support.

• Unique Dual-Action Antioxidant: Renowned for its ability to function in both water and fat environments, providing widespread cellular protection and helping shield the body from oxidative stress¹.

• Supports Metabolic & Nerve Health: Formulated to help support healthy blood sugar levels and balanced glucose metabolism, while also promoting healthy nerve function.

• Synergistic Formula Potential: Its antioxidant effects may be amplified when paired with others, such as vitamins C and E³, for enhanced overall cellular resilience and a more balanced, healthy body.

• Commitment to Purity & Quality: Every batch is "Lab Tested for Purity", ensuring it is free from contaminants like pesticides and heavy metals. Made with clean, natural ingredients crafted to high wellness standards.

Important Disclaimer:

• This product is a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease.

• These statements have not been evaluated by the Food and Drug Administration (FDA).

• Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medications, or have a medical condition. Not intended for individuals under 18.

• Gallery images are for reference only. Actual product details may vary.

References:

1. Ziegler, Dan, Phillip A. Low, William J. Litchy, Andrew J. M. Boulton, Aaron I. Vinik, Roy Freeman, Rustem Samigullin, Hans Tritschler, Ullrich Munzel, and Joachim Maus. “Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 Trial.” Diabetes Care 34, no. 9 (2011): 2054-2060.
2. Ziegler, Dan, Phillip A. Low, William J. Litchy, Andrew J. M. Boulton, Aaron I. Vinik, Roy Freeman, Rustem Samigullin, Hans Tritschler, Ullrich Munzel, and Joachim Maus. “Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 Trial.” Diabetes Care 34, no. 9 (2011): 2054-2060.
3. Linus Pauling Institute. “Lipoic Acid.” Micronutrient Information Center, Oregon State University. Accessed January 8, 2025.